Acetohexamide - CAS 968-81-0
Catalog number:
968-81-0
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C15H20N2O4S
Molecular Weight:
324.40
COA:
Inquire
Targets:
Others
Description:
Acetohexamide, a sulfonylurea derivative, is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone. It is a hyopglycemic agent with moderate uricosuric activity. It stimulates the pancreas to secrete insulin and is used as an oral hypoglycemic agent. It was developed by Eli Lilly and Company and has been listed.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98 %
Appearance:
White solid
Synonyms:
1-((p-Acetylphenyl)sulfonyl)-3-cyclohexyl-ure;4-Acetyl-n-((cyclohexylamino)carbonyl)-benzenesulfonamid;Dymelor; Acetohexamid;Gamadiabet;Dimelin;Dimelor;1-(4-Acetylphenyl)sulfonyl-3-cyclohexylurea;Hypoglicil;Metaglucina;Minoral;N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea;Ordimel;Tsiklamid;U 14812
Solubility:
DMSO: 39 mg/ml
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Acetohexamide is used to treat diabetes mellitus type 2. It is used as an oral hypoglycemic agent.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams to Kilograms
Melting Point:
188-190 °C
Density:
1.30±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
VGZSUPCWNCWDAN-UHFFFAOYSA-N
InChI:
InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)
Canonical SMILES:
CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2
Current Developer:
Acetohexamide was developed by Eli Lilly and Company and has been listed.
1.Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography.
Zheng X1, Podariu M1, Matsuda R1, Hage DS2. Anal Bioanal Chem. 2016 Jan;408(1):131-40. doi: 10.1007/s00216-015-9082-7. Epub 2015 Oct 13.
Ultrafast affinity extraction and a two-dimensional high performance affinity chromatographic system were used to measure the free fractions for various drugs in serum and at typical therapeutic concentrations. Pooled samples of normal serum or serum from diabetic patients were utilized in this work. Several drug models (i.e., quinidine, diazepam, gliclazide, tolbutamide, and acetohexamide) were examined that represented a relatively wide range of therapeutic concentrations and affinities for human serum albumin (HSA). The two-dimensional system consisted of an HSA microcolumn for the extraction of a free drug fraction, followed by a larger HSA analytical column for the further separation and measurement of this fraction. Factors that were optimized in this method included the flow rates, column sizes, and column switching times that were employed. The final extraction times used for isolating the free drug fractions were 333-665 ms or less.
2.Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids.
Basiaga SB1, Hage DS. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 15;878(30):3193-7. doi: 10.1016/j.jchromb.2010.09.033. Epub 2010 Oct 23.
This report examines the use of high-performance affinity chromatography as a screening tool for studying the change in binding by sulfonylurea drugs to the protein human serum albumin (HSA) during diabetes. The effects of both the non-enzymatic glycation of HSA and the presence of fatty acids on these interactions were considered using a zonal elution format. It was found that there was a significant increase (i.e., 2.7- to 3.6-fold) in the relative retention of several sulfonylurea drugs (i.e., acetohexamide, tolbutamide, glybenclamide and gliclazide) on columns containing normal versus glycated HSA. The addition of various long chain fatty acids to the mobile phase gave the same trend in retention for the tested drugs on both the HSA and glycated HSA columns, generally leading to lower binding. Most of the fatty acids examined produced similar or moderately different relative shifts in retention; however, palmitic acid was found to produce a much larger change in retention on columns containing glycated HSA versus normal HSA under the conditions used in this study.
3.Molecular and biochemical characterisation of human short-chain dehydrogenase/reductase member 3 (DHRS3).
Lundová T1, Zemanová L2, Malčeková B3, Skarka A4, Štambergová H5, Havránková J6, Šafr M7, Wsól V8. Chem Biol Interact. 2015 Jun 5;234:178-87. doi: 10.1016/j.cbi.2014.10.018. Epub 2014 Oct 29.
Dehydrogenase/reductase (SDR family) member 3 (DHRS3), also known as retinal short-chain dehydrogenase/reductase (retSDR1) is a member of SDR16C family. This family is thought to be NADP(H) dependent and to have multiple substrates; however, to date, only all-trans-retinal has been identified as a DHRS3 substrate. The reductive reaction catalysed by DHRS3 seems to be physiological, and recent studies proved the importance of DHRS3 for maintaining suitable retinoic acid levels during embryonic development in vivo. Although it seems that DHRS3 is an important protein, knowledge of the protein and its properties is quite limited, with the majority of information being more than 15 years old. This study aimed to generate a more comprehensive characterisation of the DHRS3 protein. Recombinant enzyme was prepared and demonstrated to be a microsomal, integral-membrane protein with the C-terminus oriented towards the cytosol, consistent with its preference of NADPH as a cofactor.
4.Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography.
Tong Z1, Joseph KS, Hage DS. J Chromatogr A. 2011 Dec 9;1218(49):8915-24. doi: 10.1016/j.chroma.2011.04.078. Epub 2011 May 6.
This study examined the use of frontal analysis and high-performance affinity chromatography for detecting heterogeneous binding in biomolecular interactions, using the binding of acetohexamide with human serum albumin (HSA) as a model. It was found through the use of this model system and chromatographic theory that double-reciprocal plots could be used more easily than traditional isotherms for the initial detection of binding site heterogeneity. The deviations from linearity that were seen in double-reciprocal plots as a result of heterogeneity were a function of the analyte concentration, the relative affinities of the binding sites in the system and the amount of each type of site that was present. The size of these deviations was determined and compared under various conditions. Plots were also generated to show what experimental conditions would be needed to observe these deviations for general heterogeneous systems or for cases in which some preliminary information was available on the extent of binding heterogeneity.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 106516-24-9 Sertindole

Sertindole
(CAS: 106516-24-9)

Sertindole, a neuroleptic, is one of the newer antipsychotic medications available.

CAS 136-40-3 Phenazopyridine Hydrochloride

Phenazopyridine Hydrochloride
(CAS: 136-40-3)

Phenazopyridine Hydrochloride is a local analgesic that has been used in urinary tract disorders.

CAS 109-57-9 Allylthiourea

Allylthiourea
(CAS: 109-57-9)

Allylthiourea is a metabolic inhibitor that selective inhibits ammonia oxidation.

GNE-3500
(CAS: 1537859-24-7)

GNE-3500 has been found to be a Retinoic acid receptor-related Orphan receptor C agonist that could be probably significant in studies of some inflammatory dise...

CAS 630-56-8 17α-Hydroxyprogesterone Caproate

17α-Hydroxyprogesterone Caproate
(CAS: 630-56-8)

17α-Hydroxyprogesterone Caproate , a synthetic steroidal progestin, is an ester derivative of 17α-hydroxyprogesterone formed from caproic acid used in the treat...

CAS 115-67-3 paramethadione

paramethadione
(CAS: 115-67-3)

This active molecular is an an antiepileptic and anticonvulsant agent. It is associated with fetal trimethadione syndrome that is also called as paramethadione ...

CAS 102767-28-2 Levetiracetam

Levetiracetam
(CAS: 102767-28-2)

Levetiracetam is an anticonvulsant medication used to treat epilepsy.

CAS 249537-73-3 NFAT Inhibitor

NFAT Inhibitor
(CAS: 249537-73-3)

A selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT)

CAS 3543-75-7 Bendamustine hydrochloride

Bendamustine hydrochloride
(CAS: 3543-75-7)

Bendamustine hydrochloride is the hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Be...

CAS 213400-34-1 UPF-648

UPF-648
(CAS: 213400-34-1)

Potent and selective inhibitor of kynurenine-3-monooxygenase (KMO, or kynurenine hydroxylase) activity (IC50: 20 nM); Active (+)-(1S,2S)-enantiomer; Useful tool...

CAS 18642-23-4 Psoralidin

Psoralidin
(CAS: 18642-23-4)

Psoralidin is a furanocoumarin natural product used in Chinese medicine. Psoralidin, a PTP1B inhibitor, has been shown to have anticancer activity with a variet...

CAS 144886-17-9 CS 722

CS 722
(CAS: 144886-17-9)

CS 722 is a neuromuscular blocking agent and centrally acting muscle relaxant. It exerts its muscle relaxant action by affecting both the supraspinal structure ...

Antennapedia Peptide

Antennapedia Peptide, a cell-penetrating 16 amino acid peptide originally derived from the 60 amino acid long homeodomain of the Drosophila transcription factor...

CAS 19057-60-4 Dioscin

Dioscin
(CAS: 19057-60-4)

Dioscin is a saponin extracted and isolated from Polygonatum Zanlanscianense Pamp, showing antitumor activities.

CAS 7631-95-0 Sodium Molybdate, anhydrous

Sodium Molybdate, anhydrous
(CAS: 7631-95-0)

Sodium molybdate is used as source of molybdate and it is often used in the form of Sodium molybdate dihydrate. It inactivated both the active and inactive form...

CAS 120938-72-9 LY 243670

LY 243670
(CAS: 120938-72-9)

LY 243670 is a bio-active molecular, but detailed information were not published yet.

CAS 112887-68-0 Raltitrexed

Raltitrexed
(CAS: 112887-68-0)

Raltitrexed is a thymidylate synthase inhibitor with an IC50 of 9 nM for the inhibition of L1210 cell growth.

CAS 466-24-0 Benzoylaconine

Benzoylaconine
(CAS: 466-24-0)

Benzoylaconine is an alkaloid in the Chinese traditional medicine Radix Aconiti Lateralis Preparata.

CAS 69363-14-0 Schisanhenol

Schisanhenol
(CAS: 69363-14-0)

Schisanhenol, isolated from Schisandra rubriflora, has antioxidative effect on human LDL oxidation. The mechanism of Schisanhenol against LDL oxidation may be t...

Protease-Activated Receptor-4

Protease-Activated Receptor-4, a member of the PARs family, is activated by thrombin, trypsin and cathepsin G but also is the agonist o fproteinase-activated re...

Chemical Structure

CAS 968-81-0 Acetohexamide

Quick Inquiry

Verification code

Featured Items